Position in RLAY
as of Mar 31, 2026
· filed Apr 10, 2026
Position Value
$420,138
+$48,533 QoQ
Shares Held
42,225
-3.9% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RLAY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Intellectus Partners, LLC holds $9,451,424 across 9 Biotechnology names. RLAY ranks #8 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,715 | $2,097,717 | |
| 2 | ABCL |
AbCellera Biologics Inc.
|
546,083 | $1,905,829 | |
| 3 | CORT |
Corcept Therapeutics Inc
|
31,000 | $1,249,610 | |
| 4 | NUVB |
Nuvation Bio Inc.
|
290,417 | $1,245,888 | |
| 5 | QNCX |
Quince Therapeutics, Inc.
|
53,312 | $1,076,902 | |
| 6 | NTLA |
Intellia Therapeutics, Inc.
|
54,475 | $698,369 | |
| 7 | IOVA |
Iovance Biotherapeutics, Inc.
|
136,446 | $478,925 | |
| 8 | RLAY |
Relay Therapeutics, Inc.
This page
|
42,225 | $420,138 |
All Filings in RLAY
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $420,138 | 42,225 | Shares | Sole | 2026-04-10 | |
| 2025-12-31 | $371,605 | 43,925 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $294,538 | 56,425 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $212,530 | 61,425 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $160,933 | 61,425 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $253,071 | 61,425 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $479,139 | 67,675 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $441,241 | 67,675 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $574,858 | 69,260 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $548,958 | 49,860 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $425,209 | 50,560 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $609,913 | 48,560 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $442,795 | 26,885 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $430,047 | 28,785 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $581,284 | 25,985 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $406,355 | 24,260 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $672,527 | 22,470 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $803,680 | 26,170 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,078,136 | 34,194 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $1,245,669 | 34,044 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $859,237 | 24,855 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $405,210 | 9,750 | Shares | Sole | 2021-02-18 | |
| No filing history on record for this holder in this stock. | ||||||